An atempt of gene therapy for oral squamous cell carcinoma
An atempt of gene therapy for oral squamous cell carcinoma
批准号:
11557130
负责人:
SHINDOH Masanobu
金额:
$8.32万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000
中文摘要
由于E1 AF能激活细胞周期抑制分子p21 waf 1/cip 1的启动子活性,因此我们研究了E1 AF和Bax的激活作用,通过将bax报告质粒、E1 AF、野生型(wt)和突变型(mt)p53表达质粒转染p53不表达细胞系,用CAT(氯霉素乙酰转移酶)法测定了bax的启动子活性。CAT活性随着ElAF以剂量依赖性方式增加,并且观察到启动子活性随着wt p53和ElAF的协同增加。Western blotting检测到Bax蛋白表达。进行生长抑制测定,并且在E1 AF转染的p53缺陷细胞中观察到集落形成减少。这些结果表明,E4 orf 6是一种新发现的腺病毒癌蛋白。E4 orf 6显著增强转化的大鼠BRK和人293细胞在裸鼠中形成肿瘤的能力。E4 orf 6蛋白已被证明与p53和p73基因产物相互作用,并阻断由这些抗癌基因介导的细胞凋亡的诱导。我们研究了E4 orf 6是否可以影响p53家族以外的诱导细胞凋亡的分子,因为p53独立的细胞凋亡途径也被提出。我们证明腺病毒E4 orf 6蛋白抑制BNIP 3的凋亡活性,BNIP 3是Bcl-2家族的一组凋亡启动子的成员。E4 orf 6的表达抑制BNIP 3介导的细胞凋亡及其线粒体易位。E4或16与BNIP 3相互作用。此外,E4 orf 6的核输出信号对于E4 orf 6的这些功能是重要的。我们的数据表明,Bcl-2家族的促凋亡蛋白是转化细胞中E4 orf 6蛋白的靶点。
英文摘要
ElAF and Bax activation was investigated since ElAF was shown to activate promoter activity of p21waf1/cip1, a cell cycle inhibitory molecule.CAT (Chloramphenicol acetyl transferase) assay was carried out to determine the promoter activity of bax by transfectipn with bax reporter plasmid, ElAF, wild type (wt) or mutant (mt) p53 expression plasmids into a p53 diffident cell line. CAT activity increased with ElAF in a dose-dependent manner and synergistical increase of the promoter activity was observed with wt p53 and ElAF. Protein expression of Bax was confirmed in ElAF transfected cells by Western blotting. Growth suppression assay was performed and decreased colony formation was observed in ElAF transfected p53 diffident cells. These results suggest that ElAF associates with p53 to induce apoptosis through activating bax.E4orf6 is a newly identified viral oncoprotein of the adenovirus. E4orf6 markedly enhances the ability of transformed rat BRK and human 293 cells to form tumors in nude mice. The E4orf6 protein has been shown to interact with p53 and p73 gene products and to block the induction of apoptosis which is mediated by these antioncogenes. We investigated whether or not E4orf6 can influence molecules that induce apoptosis other than the p53 family, because p53-independent apoptosis pathways have also been proposed. We demonstrate that the adenovirus E4orf6 protein suppresses the apoptotic activity of BNIP3, a member of a group of an apoptosis initiators of the Bcl-2 family. Expression of E4orf6 inhibits BNIP3-mediated apoptosis and its mitochondrial translocation. E4orl6 interacts with BNIP3. In addition, the nuclear export signal of E4orf6 is important for these functions of E4orf6. Our data suggest that the pro-apoptotic protein of the Bcl-2 family is a target of the E4orf6 protein in transformed cells.
期刊论文(20)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Hiroumi H., Dosaka-Akita H., Yoshida K., Shindoh M., Ohbuchi T., Fujinaga K., Harada T., Hommura F., Ogura S., Kawakami Y.: "Expression of E1AF an ets-related transcription factor in human non-small cell lung cancers: Its relevance in cell motility and in
Hiroumi H.、Dosaka-Akita H.、Yoshida K.、Shindoh M.、Ohbuchi T.、Fujinaga K.、Harada T.、Hommura F.、Ogura S.、Kawakami Y.:“E1AF 与 ets 相关的表达
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hiroumi H, Dosaka-Akita H, Shindoh M et al.: "Expression of E1AF an ets-related transcription factor in human non-small cell lung cancers : Its relevance in cell motility and inivasion"Int. J. Cancer. 93. 786-791 (2001)
Hiroumi H、Dosaka-Akita H、Shindoh M 等人:“人类非小细胞肺癌中 ets 相关转录因子 E1AF 的表达:其与细胞运动和侵袭的相关性”Int。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ara T., Deyama Y., Yoshimura Y., Higashino F., Shindoh M., Matsumoto A., Fukuda H.: "Membrane type 1-matrix metalloproteinase expression is regulated by E-cadherin through the suppression of mitogen-activated protein kinase cascade"Cancer Letts.. 157. 115
Ara T.、Deyama Y.、Yoshimura Y.、Higashino F.、Shindoh M.、Matsumoto A.、Fukuda H.:“E-钙粘蛋白通过抑制丝裂原激活蛋白来调节膜 1 型基质金属蛋白酶的表达
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Aoyagi M., Higashino F., Yasuda M., Kohgo T., Sano H., Shindoh M.: "Adenovirus E4orf6 suppresses the function apoptotic activity by Bcl-2 family protein, BNIP3"Jpn. J. Oral Biol.. 44. 40-47 (2002)
Aoyagi M.、Higashino F.、Yasuda M.、Kohgo T.、Sano H.、Shindoh M.:“腺病毒 E4orf6 通过 Bcl-2 家族蛋白 BNIP3 抑制功能凋亡活性”Jpn。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Higashino F., Yasuda M., Shihdoh M.: "The cellular target proteins of adenovirus gene products"Tanpakushitsu Kakusan Koso. 45 (8). 1350-1357 (2000)
Higashino F.,Yasuda M.,Shihdoh M.:“腺病毒基因产物的细胞靶蛋白”Tanpakushitsu Kakusan Koso。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 10 条
Development of gene delivery system using nanocoloid and its application for gene targeting therapy
-
批准号:18390531
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.76万
-
财政年份:2006
-
负责人:SHINDOH Masanobu
-
依托单位:
Gene targeting therapy for oral carcinoma using adrenomedullin antagonisit.
-
批准号:16390575
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.28万
-
财政年份:2004
-
负责人:SHINDOH Masanobu
-
依托单位:
Research on factors involved in prognosis of oral carcinoma.
-
批准号:14370654
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.6万
-
财政年份:2002
-
负责人:SHINDOH Masanobu
-
依托单位:
Gene therapy for oral squamous cell carcinoma targeting tumor specific promoter activation
-
批准号:12671834
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2000
-
负责人:SHINDOH Masanobu
-
依托单位:
Inhibitory effects on tumor invasion and metastasis induced by transfection of anti-sense E1AF,an ets-oncogene family transcription factor.
-
批准号:08672063
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1996
-
负责人:SHINDOH Masanobu
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Circ_0001313/miR-338-3p经P53调控铁死亡降低结直肠癌放化疗敏感性的机制
-
批准号:2026JJ81586
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:陈燕华
-
依托单位:
基于影像组学与代谢组学特征图谱的机器学习模型在P53突变型子宫内膜癌中的临床应用研究
-
批准号:2026JJ82384
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:颜志鹏
-
依托单位:
APR-246靶向突变p53通路逆转DLBCL耐药的分子功能及机制研究
-
批准号:JCZRQNB202600696
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
黄芩素通过p53信号通路逆转胃黏膜肠上皮化生的机制研究
-
批准号:JCZRLH202601033
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
白藜芦醇通过SIRT1/p53乙酰化调控铁死亡及其在口腔鳞状细胞癌顺铂增敏中的作用研究
-
批准号:2026JJ80394
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:毛琛
-
依托单位:
基于“心理应激”从P53/AMPK通路介导线粒体能量代谢研究疏肝健脾解毒方对肝郁型三阴乳腺癌铁死亡作用机制
-
批准号:2026JJ50614
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:李琳霈
-
依托单位:
中性粒细胞弹性蛋白酶抑制剂Sivelestat通过CCN2/P53/BNIP3通路改善阿霉素心脏毒性线粒体自噬的分子机制研究
-
批准号:2026JJ30190
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:李小平
-
依托单位:
基于miR-218-5p/NDRG4/p53通路研究“阴中隐阳”手法针刺风池 穴治疗青光眼性视神经损伤的作用机制
-
批准号:JCZRLH202600426
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
GINS1通过调控肿瘤干性及PTP4A1/p53信号轴促进非小细胞肺癌发生发展及靶向干预研究
-
批准号:JCZRLH202600663
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
软饮食下Igfbp5调控p53/p21通路诱导颞下颌关节退行性变的机制研究
-
批准号:2026JJ60602
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:周典
-
依托单位: